Korsana Biosciences, Inc. (KRSA) vs Protara Therapeutics, Inc. (TARA)
A side-by-side comparison of Korsana Biosciences, Inc. and Protara Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KRSA
Korsana Biosciences, Inc.
$31.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TARA
Protara Therapeutics, Inc.
$2.56HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KRSA vs TARA
growth of $100 · dividends reinvested · last 8yKRSA -98.2% (-39.7%/yr)TARA -98.2% (-39.5%/yr)TARA compounded faster over this window
KRSA TARA
KRSA vs TARA: by the numbers
- •KRSA is the larger company ($149M vs $144M market cap).
- •Both run net losses; TARA's is the smaller (0.00% vs -353.00% net margin).
Metrics side by side
Valuation
| Metric | KRSA | TARA |
|---|---|---|
| P/S ratio | 78.28 | N/A |
| P/B ratio | 29.24 | 0.89 |
Profitability
| Metric | KRSA | TARA |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -239.78% | 0.00% |
| Net margin | -353.00% | 0.00% |
| ROE | -131.85% | -43.40% |
| ROIC | -134.15% | -47.18% |
Growth (annualized)
| Metric | KRSA | TARA |
|---|---|---|
| Revenue CAGR (5Y) | -11.98% | N/A |
| Total return CAGR (5Y) | -40.41% | -16.45% |
Frequently asked
- How have KRSA and TARA total returns compared?
- Over the past 5 years, KRSA delivered -40.41% and TARA delivered -16.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.